# Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study

> **NCT00469326** · PHASE3 · COMPLETED · sponsor: **University Hospital, Motol** · enrollment: 200 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00469326
- **Lead sponsor:** University Hospital, Motol
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2009-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00469326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00469326, "Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00469326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*